First report of a persistent oropharyngeal infection of type 2 vaccine-derived poliovirus (iVDPV2) in a primary immune deficient (PID) patient after eradication of wild type 2 poliovirus

Merav Weil, Galia Rahav, Raz Somech, Tali Stauber, Jacqueline Alfandari, Leah Weiss, Ilana Silberstein, Victoria Indenbaum, Itay Bar Or, Ella Mendelson, Danit Sofer, Lester M. Shulman

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

This is the first report of persistent oropharyngeal mucosal infection with type 2 poliovirus (iVDPV2) in a primary immune deficient patient (PID) after wild type 2 poliovirus eradication. The iVDPV2 also established persistence in the gut. iVDPV2 at both loci evolved independently. Persistent oral infections present a potential risk for oral-oral as well as fecal-oral poliovirus transmission during transition to a poliovirus 2-free world.

Original languageEnglish
Pages (from-to)40-43
Number of pages4
JournalInternational Journal of Infectious Diseases
Volume83
DOIs
StatePublished - Jun 2019
Externally publishedYes

Keywords

  • Contact isolation
  • Droplet isolation
  • Oropharyngeal mucosa
  • Primary immune deficiency (PID)
  • Stools
  • Type 2 vaccine-derived poliovirus (iVDPV2)

Fingerprint

Dive into the research topics of 'First report of a persistent oropharyngeal infection of type 2 vaccine-derived poliovirus (iVDPV2) in a primary immune deficient (PID) patient after eradication of wild type 2 poliovirus'. Together they form a unique fingerprint.

Cite this